DC 7718Hematologic & Lymphatic System38 CFR § 4.117Last verified: APR 22, 2026

Essential thrombocythemia and primary myelofibrosis

The VA rates Essential thrombocythemia and primary myelofibrosis under Diagnostic Code 7718 across 4 severity levels, from 0% to 100%. At 100%, veterans receive $3939/month or more in compensation.

Also available: View rating schedule for DC 7718

Rating schedule — DC 7718 at a glance

Minimum rating
0%

Lowest schedular rating available

Maximum rating
100%

Full schedular disability

Rating tiers
4

0%, 30%, 70%, 100%

CFR section
§ 4.117

Part 4 rating schedule

Body system
Hematologic & Lymphatic System
Secondary conditions
0

None mapped

What are the VA rating criteria for Essential thrombocythemia and primary myelofibrosis?

RatingCriteria
0%

Asymptomatic

30%

Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count of 200,000-400,000, or white blood cell (WBC) count of 4,000-10,000

70%

Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count <500 &#xD7; 10/L 9

100%

Requiring either continuous myelosuppressive therapy, or, for six months following hospital admission for any of the following treatments: peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment

Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count <500 &#xD7; 10/L 9

Common Questions About Essential thrombocythemia and primary myelofibrosis VA Ratings

What is the VA rating range for Essential thrombocythemia and primary myelofibrosis?

The VA rates Essential thrombocythemia and primary myelofibrosis under Diagnostic Code 7718 at 0%, 30%, 70%, 100%. The minimum 0% rating requires: Asymptomatic. The maximum 100% rating requires: Requiring either continuous myelosuppressive therapy, or, for six months following hospital admission for any of the following treatments: peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment.

Which 38 CFR diagnostic code does the VA use for Essential thrombocythemia and primary myelofibrosis?

The VA rates Essential thrombocythemia and primary myelofibrosis under Diagnostic Code (DC) 7718, governed by 38 CFR 38 CFR § 4.117. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.

What is the difference between a 0% and a 100% rating for Essential thrombocythemia and primary myelofibrosis?

A 0% rating requires: Asymptomatic. A 100% rating requires: Requiring either continuous myelosuppressive therapy, or, for six months following hospital admission for any of the following treatments: peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment. The difference typically reflects the frequency, severity, or functional impact of the condition as documented in medical records and C&P examination findings.

Can Essential thrombocythemia and primary myelofibrosis qualify for TDIU?

Yes — a 100% rating for Essential thrombocythemia and primary myelofibrosis alone meets the single-disability threshold for TDIU (38 CFR § 4.16). If the condition prevents substantially gainful employment, the veteran is compensated at the 100% rate without a schedular 100% rating.

What evidence supports a higher rating for Essential thrombocythemia and primary myelofibrosis?

The key evidence for Essential thrombocythemia and primary myelofibrosis is documentation of how the condition affects daily functioning. Treatment records showing worsening symptoms, functional limitations documented by your provider, and buddy statements describing observable impact on daily life all strengthen the claim. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.

What happens at the C&P exam for Essential thrombocythemia and primary myelofibrosis?

The C&P examiner uses a Hematologic & Lymphatic System DBQ and evaluates your condition against the DC 7718 rating criteria. The examiner documents symptom frequency, severity, and functional impact. Bring all treatment records and describe your worst days, not your best — the VA rates on the full clinical picture across time, not a snapshot of one good day.

Get a Personalized Rating Analysis

VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.

Discover Your Benefits